These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Forms of gamma globulin for intravenous use. South MA Cutis; 1978 Nov; 22(5):554, 566, 636. PubMed ID: 83222 [No Abstract] [Full Text] [Related]
26. [Measurement of the anti-complementary activity of gamma-globulin preparations for intravenous administration]. Malgras J; Hauptmann G; Zorn JJ; Waitz R Rev Fr Transfus; 1970 Jun; 13(2):173-80. PubMed ID: 4100946 [No Abstract] [Full Text] [Related]
27. [Therapy with gamma globulins. When, with what, with what success or risk?]. Seifert J; Duswald KH; Ring J Fortschr Med; 1980 Apr; 98(14):533-8. PubMed ID: 6154635 [No Abstract] [Full Text] [Related]
28. Development of an intravenous gamma-globulin with Fc activities. II. Reconversion of S-sulfonated human gamma-globulin into the original gamma-globulin. Masuho Y; Tomibe K; Watanabe T; Fukumoto Y Vox Sang; 1977; 32(5):290-5. PubMed ID: 67714 [TBL] [Abstract][Full Text] [Related]
29. [In vivo behavior of lymphocytes in patients with chronic lymphadenosis under the effect of anti-lymphadenosis gamma globulin]. Preussner S; Frick G Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(2):183-95. PubMed ID: 4136381 [No Abstract] [Full Text] [Related]
31. Turnover of standard-gammaglobulin, pH-4-gammaglobulin and pepsin desaggregated gammaglobulin and clinical implications. Koblet H; Barandun S; Diggelmann H Vox Sang; 1967 Jul; 13(1):93-102. PubMed ID: 4166596 [No Abstract] [Full Text] [Related]
32. [Passive immunization of children in the course of severe diseases with a gamma globulin preparation (Gamma Venin) for intravenous use]. Gebala A; Modzelewska I Pol Tyg Lek; 1970 Jul; 25(29):1074-6. PubMed ID: 4194778 [No Abstract] [Full Text] [Related]
33. [Intravenous administration of gamma globulin in idiopathic thrombocytopenic purpura]. Sallerfors B; Persson S Lakartidningen; 1983 Nov; 80(45):4296-7. PubMed ID: 6197594 [No Abstract] [Full Text] [Related]
34. Development of an intravenous gamma-globulin with Fc activities. I. Preparation and characterization of S-sulfonated human gamma-globulin. Masuho Y; Tomibe K; Matsuzawa K; Ohtsu A Vox Sang; 1977; 32(3):175-81. PubMed ID: 67713 [TBL] [Abstract][Full Text] [Related]
37. The prevention of post-transfusion hepatitis: a challenge to physicians and blood banks. Chalmers TC; Forrest JN; Grady GF Trans Am Clin Climatol Assoc; 1969; 80():15-22. PubMed ID: 4185012 [No Abstract] [Full Text] [Related]
38. [Potentials for the combined use of gentamycin with gamma globulin and vitamins]. Dilov P; Boiadzhieva A; Iotov M; Dimitrov K Vet Med Nauki; 1981; 18(9):23-8. PubMed ID: 6178208 [TBL] [Abstract][Full Text] [Related]
39. Survival studies on a commercial preparation of intravenous human gammaglobulin labelled with 131-I. Wells JV; Penny R Australas Ann Med; 1969 Aug; 18(3):271-6. PubMed ID: 4187132 [No Abstract] [Full Text] [Related]
40. [High-dose intravenous gamma globulin therapy for acute leukemia refractory to platelet transfusions]. Sano M; Nakamaki T; Miyashita T; Tomoyasu S; Tsuruoka N Rinsho Ketsueki; 1985 Sep; 26(9):1496-500. PubMed ID: 2418224 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]